D. Ruiter

E. Danen, D. Ruiter, G. V. van Muijen, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics.

D. Ruiter, R. D. de Waal, J. R. Westphal, 1993, The Journal of investigative dermatology.

c‐myc down‐regulates class I HLA expression in human melanomas.

R. Versteeg, D. Ruiter, P. Schrier, 1988, The EMBO journal.

Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.

C. Figdor, D. Ruiter, G. Adema, 1993, The American journal of pathology.

A monoclonal antibody specific for cells of the melanocyte lineage.

D. Ruiter, J. Calafat, P. Rümke, 1988, The American journal of pathology.

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease.

D. Ruiter, H. Spits, T. D. de Witte, 2000, Blood.

A combination of anti-CD 3 and anti-CD 7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease

D. Ruiter, H. Spits, F. Preijers, 2022 .

Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study.

D. Ruiter, J. Koopman, T. D. de Witte, 2001, International journal of pharmaceutics.

Characterization of melanoma‐associated surface antigens involved in the adhesion and motility of human melanoma cells

C. Figdor, D. Ruiter, A. T. Te Velde, 1986, International journal of cancer.

Application of Monoclonal Antibodies in Tumor Pathology

G. Fleuren, D. Ruiter, S. Warnaar, 1987, Developments in Oncology.

Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay.

D. Ruiter, R. D. de Waal, N. Lubsen, 1994, Thrombosis and haemostasis.

The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis.

D. Ruiter, R. D. de Waal, A. J. Pötgens, 1995, Biological chemistry Hoppe-Seyler.

Validation of Diffusion Weighted Imaging of cortical anisotropy by means of a histological stain for myelin

van Cappellen van Walsum A-M., M. Kleinnijenhuis, P. Dederen, 2011 .

Intermediate filaments in Merkel cell tumors.

D. Ruiter, S. Warnaar, G. V. van Muijen, 1985, Human pathology.

Monoclonal antibodies in detection of choroidal melanoma

P. Jong, D. Ruiter, S. Duinen, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites

D. Ruiter, P. D. De Mulder, J. Manni, 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma.

P. van den Broek, D. Ruiter, P. D. De Mulder, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Demonstration of Intermediate Cells during Human Prostate Epithelial Differentiation In Situ and In Vitro Using Triple-Staining Confocal Scanning Microscopy

J. Schalken, D. Ruiter, C. H. Kaa, 2000, Laboratory Investigation.

Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma.

G. Fleuren, D. Ruiter, U. Jonas, 1986, The American journal of pathology.

The lysosomal copper concentration in the liver in primary biliary cirrhosis.

D. Ruiter, A. Janssens, M. J. van Noord, 2008, Liver.

Uptake by liver cells of endotoxin following its intravenous injection.

E. Wisse, D. Ruiter, J. van der Meulen, 1981, Laboratory investigation; a journal of technical methods and pathology.

Radiological imaging of teratological fetuses: what can we learn?

D. Bosboom, D. Ruiter, J. V. van Asten, 2017, Insights into Imaging.

Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28

D. Ruiter, M. Bernsen, L. Hakansson, 2002, Cancer Immunology, Immunotherapy.

The proliferative response of human T cells to allogeneic IFN-gamma-treated endothelial cells is mediated via both CD2/LFA-3 and LFA-1/ICAM-1 and -2 adhesion pathways.

D. Ruiter, R. D. de Waal, R. Koene, 1993, Transplant immunology.

Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma

D. Ruiter, S. V. van Duinen, P. Rümke, 1984, Cancer.

MHC antigens in human melanomas.

D. Ruiter, S. Ferrone, V. Mattijssen, 1991, Seminars in cancer biology.

Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas.

D. Ruiter, A. Sutter, S. Goodman, 1997, International journal of cancer.

Class II HLA Antigens in Benign and Malignant Lesions of Melanocytic Origin

D. Ruiter, S. Ferrone, S. Duinen, 1986 .

Glycoconjugate profile and cd44 expression in human melanoma cell lines with different metastatic capacity

E. Danen, D. Ruiter, J. Veerkamp, 1995, International journal of cancer.

Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.

D. Ruiter, E. Bröcker, S. Ferrone, 1988, The Journal of investigative dermatology.

HRAS-mutated Spitz Tumors: A Subtype of Spitz Tumors With Distinct Features

A. Klaasen, D. Ruiter, W. Mooi, 2010, The American journal of surgical pathology.

T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions.

M. Verbeek, D. Ruiter, R. D. de Waal, 1995, Journal of immunology.

Monoclonal antibody PAL-E specific for endothelium.

D. Ruiter, G. Dingjan, R. Schlingemann, 1985, Laboratory investigation; a journal of technical methods and pathology.

DIAGNOSIS OF RENAL ALLOGRAFT REJECTION BY MACROPHAGE IMMUNOSTAINING WITH A CD14 MONOCLONAL ANTIBODY, WT14

D. Ruiter, A. Hoitsma, M. Bogman, 1989, The Lancet.

Epitopes of Components of the Plasminogen Activation System are Re-exposed in Formalin-fixed Paraffin Sections by Different Retrieval Techniques

D. Ruiter, M. Kramer, G. V. van Muijen, 1998 .

Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques.

D. Ruiter, M. Kramer, G. V. van Muijen, 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Cytokeratin and neurofilament in lung carcinomas.

D. Ruiter, G. V. van Muijen, F. Prins, 1984, The American journal of pathology.

Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy.

N. de Leeuw, J. Galama, D. Ruiter, 1999, Journal of clinical pathology.

Anti‐endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysis

D. Ruiter, H. Kwast, J. R. Westphal, 1994, Clinical and experimental immunology.

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

W. V. van Venrooij, R. Hoet, D. Ruiter, 1991, Annals of the rheumatic diseases.

Phenotypic dynamics of tumor progression in human malignant melanoma

D J Ruiter, D. Ruiter, E. Bröcker, 1985, International journal of cancer.

Expression of HLA antigens in paraffin sections of uveal melanomas

D. Ruiter, M. Jager, D. Wolff-Rouendaal, 1986, Documenta Ophthalmologica.

Expression of cd44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential

E. Danen, D. Ruiter, G. V. van Muijen, 1995, International journal of cancer.

Immunohistologic evidence for the malignant potential of congenital melanocytic nevi.

J. Johnson, D. Ruiter, E. Bröcker, 1989, The Journal of investigative dermatology.

Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis

D. Ruiter, W. Bergman, E. Scheffer, 1988, Cancer.

Heterogeneous expression of melanoma-associated antigens in uveal melanomas.

D. Ruiter, M. Jager, D. de Wolff-Rouendaal, 1987, Current eye research.

EXPRESSION AND SUSCEPTIBILITY TO MODULATION BY INTERFERONS OF HLA CLASS I AND II ANTIGENS ON MELANOMA CELLS. IMMUNOHISTOCHEMICAL ANALYSIS AND CLINICAL RELEVANCE

D. Ruiter, E. Bröcker, S. Ferrone, 1986, Journal of immunogenetics.

Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.

D. Ruiter, W. Bergman, G. Dingjan, 1985, The Journal of investigative dermatology.

Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.

D. Ruiter, S. Ferrone, W. Bergman, 1984, Cancer research.

Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma

D. Ruiter, H. Schaafsma, F. Ramaekers, 1993, The Journal of pathology.

The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects.

D. Ruiter, M. Denijn, 1993, Melanoma research.

Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

P. Wesseling, M. Verbeek, D. Ruiter, 1994, The American journal of pathology.

Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma.

M. Greaves, D. Ruiter, J. Denekamp, 1990, Laboratory investigation; a journal of technical methods and pathology.

Components of the plasminogen activation system in uveal melanoma—a clinico‐pathological study

P. Quax, H. Verspaget, U. Weidle, 1995, The Journal of pathology.

Magnetic resonance imaging in the diagnosis and staging of renal masses: a critical appraisal and comparison with computed tomography

J. Bloem, D. Ruiter, U. Jonas, 1988, World Journal of Urology.

Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis.

A. Eggermont, D. Ruiter, R. D. de Waal, 1998, The American journal of pathology.

Ichthyosis bullosa of Siemens: Further delineation of the phenotype

R. Happle, D. Ruiter, P. Steijlen, 2004, Archives of Dermatological Research.

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.

D. Ruiter, S. Ferrone, G. Griffioen, 1987, British Journal of Cancer.

Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.

M. Mihm, A. Sober, D. Ruiter, 1982, Journal of immunology.

Immunohistochemistry and special diagnostic techniques

A. Cochran, D. Ruiter, W. Mooi, 2003 .

Photocarcinogenesis in human adult skin grafts.

C. Berking, M. Herlyn, D. Ruiter, 2002, Carcinogenesis.

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

A. Eggermont, D. Ruiter, A. Eggermont, 1996, British Journal of Cancer.

Coexpression of Integrin αvβ3 and Matrix Metalloproteinase-2 (MMP-2) Coincides with MMP-2 Activation: Correlation with Melanoma Progression

J. Becker, D. Ruiter, J. R. Westphal, 2000 .

Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma.

E. Danen, D. Ruiter, G. V. van Muijen, 1995, Cancer surveys.

TCA: a polymorphic genetic marker in leukemias and melanoma cell lines.

D. Ruiter, A. van Leeuwen, P. Schrier, 1986, Blood.

Reticulum cell sarcomas (large cell lymphomas) presenting in the skin. High frequency of true histiocytic lymphoma

C. Meijer, D. Ruiter, R. Willemze, 1982, Cancer.

Induction of a-Smooth Muscle Actin Expression in Cultured Human Brain Pericytes by Transforming Growth Factor-f31

P. Wesseling, M. Verbeek, D. Ruiter, 2007 .

Primary “Reticulum Cell Sarcoma” of the Skin:High Frequency of True Histiocytic Lymphoma (Histiocytic Sarcoma)

R. Willemze, D. Ruiter, W. Vloten, 1982 .

Malignant lymphoma of true histiocytic origin: Histiocytic Sarcoma

C. Cornelisse, D. Ruiter, C. Meijer, 2004, Virchows Archiv A.

Immunological, cytochemical and ultrastructural studies in lymphomatoid papulosis

C. Meijer, R. Willemze, D. Ruiter, 1983, The British journal of dermatology.

Chemodectoma (paraganglioma) of the larynx.

D. Ruiter, G. Hordijk, F. Bosman, 1981, Clinical otolaryngology and allied sciences.

Accessory Function of Endothelial Cells in Anti‐CD3‐Induced T‐Cell Proliferation: Synergism with Monocytes

D. Ruiter, R. Koene, J. R. Westphal, 1992, Scandinavian journal of immunology.

Diagnostic application of panels of antibodies in mucosal melanomas of the head and neck

G. Snow, C. Meijer, D. Ruiter, 1988, Cancer.

Evaluation of consensus development conference on cutaneous melanoma in The Netherlands

D. Ruiter, A. Casparie, F. Rampen, 1990 .

αv‐Integrins in human melanoma: Gain of αvβ3 and loss OF αvβ5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice

E. Danen, D. Ruiter, G. V. van Muijen, 1995 .

Endothelial Cells Promote Anti‐CD3‐Induced T‐cell Proliferation via Cell‐Cell Contact Mediated by LFA‐1 and CD2

D. Ruiter, R. Koene, J. R. Westphal, 1993, Scandinavian journal of immunology.

Characteristics and possible function of endoglin, a TGF-beta binding protein.

D. Ruiter, R. D. de Waal, J. R. Westphal, 1993, Behring Institute Mitteilungen.

In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities

D. Ruiter, W. Leenders, R. D. de Waal, 2001 .

In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities.

D. Ruiter, W. Leenders, R. D. de Waal, 2001, International journal of cancer.

Expression of integrin αvβ3 correlates with activation of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) and matrix metalloproteinase‐2 (MMP‐2) in human melanoma cells in vitro and in vivo

D. Ruiter, G. V. van Muijen, A. A. van Kraats, 2000 .

Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.

R. Willemze, D. Ruiter, W. Bergman, 1985, The Journal of investigative dermatology.

[Melanoma-stroma interactions and melanoma progression].

M. Herlyn, D. Ruiter, 2003, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Transient Induction of E‐Selectin Expression Following TNFα‐Based Isolated Limb Perfusion in Melanoma and Sarcoma Patients Is Not Tumor Specific

A. Eggermont, M. Verbeek, D. Ruiter, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

The Disintegrin Eristostatin Interferes with Integrin α4β1 Function and with Experimental Metastasis of Human Melanoma Cells

E. Danen, D. Ruiter, C. Marcinkiewicz, 1998 .

Molecular analysis of multifocal prostate cancer lesions

G. Miller, J. Schalken, A. van Bokhoven, 1999, The Journal of pathology.

Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study.

M. Mihm, D. Ruiter, G. Murphy, 1983, The Journal of investigative dermatology.

Dendritic reticulum cell sarcoma? Four cases of a lymphoma probably derived from dendritic reticulum cells of the follicular compartment

D. Ruiter, C. Meijer, P. Spaander, 1982, Histopathology.

Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.

D. Ruiter, G. V. van Muijen, A. A. van Kraats, 2000, International journal of cancer.

Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.

J. Becker, D. Ruiter, G. V. van Muijen, 2000, The Journal of pathology.

Macrophages in melanocytic naevi

D. Ruiter, E. Bröcker, H. Hamm, 2004, Archives of Dermatological Research.

Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.

E. Danen, D. Ruiter, G. V. van Muijen, 1996, Biochemical and biophysical research communications.

Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors.

D. Ruiter, M. Ponec, S. Warnaar, 1984, The American journal of pathology.

Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.

D. Ruiter, K. V. van Erpecum, A. Janssens, 1988, The American journal of gastroenterology.

How to achieve synergy between medical education and cognitive neuroscience? An exercise on prior knowledge in understanding

G. Fernández, D. Ruiter, M. V. van Kesteren, 2010, Advances in health sciences education : theory and practice.

Phenotype of Normal Cutaneous Microvasculature

D. Ruiter, E. Bröcker, R. D. Waal, 1996 .

Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours

D. Ruiter, M. Ligtenberg, W. Mooi, 2002, The Journal of pathology.

Intermediate cells in normal and malignant prostate epithelium express c‐MET: Implications for prostate cancer invasion

J. Schalken, D. Ruiter, G. V. van Leenders, 2002, The Prostate.

Intermediate cells in normal and malignant prostate epithelium express c‐MET: Implications for prostate cancer invasion

J. Schalken, D. Ruiter, G. V. van Leenders, 2002 .

Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.

E. Lane, J. Schalken, D. Ruiter, 1991, The American journal of pathology.

Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma

D. Ruiter, M. Bernsen, L. Hakansson, 2003, Cancer Immunology, Immunotherapy.

Diffuse cutaneous mastocytosis with multiple cutaneous mastocytomas

R. Willemze, D. Ruiter, W. Vloten, 1980, The British journal of dermatology.

Renal oncocytoma: a report of two cases with immunohistochemical evaluation.

D. Ruiter, E. Oosterwijk, J. Krieken, 1988, Human pathology.

Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis.

D. Ruiter, R. D. de Waal, G. V. van Muijen, 1996, Current opinion in oncology.

Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections

D. Ruiter, R. Schlingemann, E. Hagen, 1986, Histopathology.

Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract

D. Ruiter, H. Schaafsma, F. Ramaekers, 2004, Histochemistry.

Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13.

D J Ruiter, D. Ruiter, M. Ponec, 1986, Experimental cell research.

Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.

D J Ruiter, E. Lane, D. Ruiter, 1990, The American journal of pathology.

Expression of Calcyclin in Human Melanocytic Lesions 1

D. Ruiter, H. Bloemers, M. Weterman, 2006 .

Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice.

J. Kuźnicki, D. Ruiter, G. V. van Muijen, 1992, Cancer research.

Nadroparin-Induced Calcinosis cutis in Renal Transplant Recipients

D. Ruiter, F. V. van Haren, L. Hilbrands, 2001, Nephron.

Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid

R. Happle, D. Ruiter, P. Steijlen, 1993, Archives of Dermatological Research.

Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus.

D. Ruiter, P. V. D. van de Kerkhof, E. D. De Jong, 1991, Journal of the American Academy of Dermatology.

Radiation-induced head and neck tumours: is the skin as sensitive as the thyroid gland?

D. Ruiter, W. V. van Daal, J. Hermans, 1983, European journal of cancer & clinical oncology.

Metastatic Skin Calcification

D. Ruiter, W. Vloten, E. Scheffer, 1980 .

Epidermal Langerhans cells in erythrokeratodermia variabilis

D. Ruiter, G. Bots, J. van der Schroeff, 1982, Archives of Dermatological Research.

INK4-ARF and p53 Mutations in Metastatic Cutaneous Squamous Cell Carcinoma: Case Report and Archival Study on the Use of Ink4a-ARF and p53 Mutation Analysis in Identification of the Corresponding Primary Tumor

P. D. de Wilde, D. Ruiter, M. Ligtenberg, 2005, The American journal of surgical pathology.

The tumor microenvironment: a critical determinant of neoplastic evolution.

L. Coussens, D. Ruiter, G. V. van Muijen, 2003, European journal of cell biology.

Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.

D. Ruiter, R. D. de Waal, R. Clarijs, 2001, Investigative Ophthalmology and Visual Science.

Functional and morphological abnormalities of the parathyroid glands as late effects of irradiation for benign diseases.

D. Ruiter, W. V. van Daal, B. Goslings, 1985, The Netherlands journal of medicine.

Hypomelanotic macules in tuberous sclerosis

D. Ruiter, W. Vloten, S. Duinen, 1981, Archives of Dermatological Research.

Molecular cytogenetics of cutaneous melanocytic lesions – diagnostic, prognostic and therapeutic aspects

D. Ruiter, W. Blokx, M. Van Dijk, 2010, Histopathology.

Current diagnostic problems in melanoma pathology.

D. Ruiter, C. M. Ferrier, M. Van Dijk, 2003, Seminars in cutaneous medicine and surgery.

Multiplex Ligation-Dependent Probe Amplification for the Detection of Chromosomal Gains and Losses in Formalin-Fixed Tissue

D. Ruiter, H. Straatman, J. Jeuken, 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

DNA in situ hybridization as a diagnostic tool in the discrimination of melanoma and spitz naevus

D. Ruiter, G. V. van Muijen, P. Poddighe, 1994, The Journal of pathology.

Loss of adhesion to basement membrane components but not to keratinocytes in proliferating melanocytes.

E. Danen, D. Ruiter, N. Smit, 1996, European journal of cell biology.

A staining procedure for melanin in semithin and ultrathin epoxy section

D. Ruiter, S. Duinen, D. Ruiter, 1983, Histopathology.

Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression.

E. Danen, D. Ruiter, E. Bröcker, 1994, Histopathology.

Matrix metalloproteinases in human melanoma.

D. Ruiter, G. V. van Muijen, J. R. Westphal, 2000, The Journal of investigative dermatology.

The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines.

U. Weidle, D. Ruiter, G. V. van Muijen, 2003, Gene.

Correlation of scintigraphy with short interval autopsy in malignant focal liver disease. A study of 59 cases

D. Ruiter, E. Pauwels, P. Spaander, 1977, Cancer.

Secreting peritoneal mesothelioma

D. Ruiter, M. Boon, J. Andel, 1981, Virchows Archiv A.

Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.

D. Ruiter, R. D. de Waal, P. V. D. van de Kerkhof, 1991, The American journal of pathology.

Differential Diagnosis of Metastatic Lesions in the Lung

D. Ruiter, 1986 .

Molecular genetics and epidemiology of prostate carcinoma.

G. Miller, J. Schalken, F. Debruyne, 1999, Endocrine reviews.

Thymosin β‐10 expression in melanoma cell lines and melanocytic lesions: A new progression marker for human cutaneous melanoma

D. Ruiter, G. V. van Muijen, H. Bloemers, 1993, International journal of cancer.

Antigens CTp11, a Novel Member of the Family of Human Cancer/Testis

U. Weidle, D. Ruiter, I. Cornelissen, 1999 .

The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin αvβ3 expression

P. Wesseling, D. Ruiter, B. Küsters, 2001 .

The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression.

P. Wesseling, D. Ruiter, B. Küsters, 2001, International journal of cancer.

Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis

P. Wesseling, D. Ruiter, R. Waal, 2007, Oncogene.

nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts

N. Ajubi, D. Ruiter, G. V. van Muijen, 1995, International journal of cancer.

Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

N. Hayward, S. van der Flier, D. Ruiter, 1996, The American journal of pathology.

Increasing epidermal growth factor receptor expression in human melanocytic tumor progression.

D. Ruiter, S. Moretti, G. V. van Muijen, 1992, The Journal of investigative dermatology.

Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients.

D. Ruiter, P. C. van de Kerkhof, E. D. De Jong, 2002, Archives of dermatology.

Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.

D. Ruiter, R. D. de Waal, N. Lubsen, 1996, The American journal of pathology.

Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney

D. Ruiter, U. Jonas, P. Hoedemaeker, 1986, International journal of cancer.

Melanoma-stroma interactions: structural and functional aspects.

D. Elder, M. Herlyn, D. Ruiter, 2002, The Lancet. Oncology.

Aneurysmal bone cysts. A clinicopathological study of 105 cases

D. Ruiter, T. V. van Rijssel, E. A. Der Van Velde, 1977, Cancer.

Tumor dependent growth kinetics of human tumor xenografts using the subrenal capsule assay.

L. V. van Putten, D. Ruiter, T. Smink, 1985, European journal of cancer & clinical oncology.

Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugs.

L. V. van Putten, D. Ruiter, T. Smink, 1984, European journal of cancer & clinical oncology.

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.

B. Nielsen, D. Ruiter, M. Schmitt, 1998, European journal of cancer.

Aneurysmal bone cyst and telangiectatic osteosarcoma

D. Ruiter, C. Cornelisse, E. A. Velde, 1977, Virchows Archiv A.

P16 and p53 Expression in (Pre)Malignant Epidermal Tumors of Renal Transplant Recipients and Immunocompetent Individuals

D. Ruiter, J. Bulten, P. Kerkhof, 2003, Modern Pathology.

Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis

D J Ruiter, D. Ruiter, E. Bröcker, 1997, Melanoma research.

Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.

D. Ruiter, R. D. de Waal, N. Lubsen, 1995, The American journal of pathology.

Tumour metastasis: is tissue an issue?

D. Ruiter, R. D. de Waal, J. V. van Krieken, 2001, The Lancet. Oncology.

Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients

T. Wobbes, D. Ruiter, R. D. de Waal, 2004, International journal of cancer.

On the effect of biochemotherapy in metastatic malignant melanoma: An immunopathological evaluation

D. Ruiter, M. Bernsen, L. Hakansson, 2003, Melanoma research.

[Revised consensus melanoma of the skin].

D. Ruiter, B. Kroon, P. Rümke, 1990, Nederlands tijdschrift voor geneeskunde.

Consensus on the management of malignant melanoma of the skin in The Netherlands. Dutch Melanoma Working Party.

J. Coebergh, D. Ruiter, W. Bergman, 1999, Melanoma research.

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

D. Ruiter, D. Ruiter, I. Cornelissen, 1999, British Journal of Cancer.

Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

J. A. van der Laak, P. Wesseling, D. Ruiter, 1998, Human pathology.

Early and Extensive Contribution of Pericytes/Vascular Smooth Muscle Cells to Microvascular Proliferation in Glioblastoma Multiforme: An Immuno‐light and Immuno‐electron Microscopic Study

P. Wesseling, P. Burger, D. Ruiter, 1995, Journal of neuropathology and experimental neurology.

The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells.

E. Danen, D. Ruiter, G. V. van Muijen, 1998, Experimental cell research.

Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.

J. A. van der Laak, P. Wesseling, P. D. de Wilde, 1997, British Journal of Cancer.

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

C. Figdor, C. Punt, D. Ruiter, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

CTp11, a novel member of the family of human cancer/testis antigens.

U. Weidle, D. Ruiter, G. V. van Muijen, 1999, Cancer research.

Cholescintigraphy with99mTc-diethyl-IDA for the detection of rejection of auxiliary liver transplants in pigs

P. Hennis, D. Ruiter, J. Blom, 2004, European Journal of Nuclear Medicine.

Pathologic staging of melanoma.

J. J. van den Oord, D. Ruiter, A. Spatz, 2002, Seminars in oncology.

Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx

D. Ruiter, H. Schaafsma, F. Ramaekers, 2005, European Archives of Oto-Rhino-Laryngology.

Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords.

D. Ruiter, H. Schaafsma, F. Ramaekers, 1996, Acta oto-laryngologica.

Analysis of N-ras mutations in human cutaneous melanoma: tumor heterogeneity detected by polymerase chain reaction/single-stranded conformation polymorphism analysis.

S. van der Flier, D. Ruiter, S. Zerp, 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Monoclonal antibody-defined human endothelial antigens as vascular markers.

D. Ruiter, R. D. de Waal, R. Schlingemann, 1989, The Journal of investigative dermatology.

The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer.

D. Ruiter, J. Oosterhuis, A. Spatz, 2002, European journal of cancer.

The role of VEGF-C staining in predicting regional metastasis in melanoma

D. Bacquer, J. Lambert, D. Ruiter, 2006, Virchows Archiv.

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

A. Eggermont, A. Testori, C. Punt, 2005, The Lancet.

Vascular endothelial growth factor‐A determines detectability of experimental melanoma brain metastasis in GD‐DTPA‐enhanced MRI.

A. Heerschap, P. Wesseling, J. Barentsz, 2003, International journal of cancer.

Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.

P. Wesseling, D. Ruiter, W. Leenders, 2002, Cancer research.

Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections.

D J Ruiter, H de Leeuw, J. A. van der Laak, 1994, Journal of neurosurgery.

Anti‐angiogenic treatment of human cancer: Pitfalls and promises

D J Ruiter, D. Ruiter, R. D. de Waal, 2000, International journal of cancer.

Class I and Class II HLA Antigens in Colorectal and Liver Carcinomas

D. Ruiter, S. Ferrone, M. Gerber, 1986 .

Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.

U. Weidle, D. Ruiter, R. D. de Waal, 1997, The American journal of pathology.

Expression of endoglin in psoriatic involved and uninvolved skin.

D. Ruiter, R. D. de Waal, P. V. D. van de Kerkhof, 1995, Journal of dermatological science.

Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds.

S Ferrone, D J Ruiter, D. Ruiter, 1989, The American journal of pathology.

Differential Expression of Endothelium‐specific Antigen PAL‐E in Vasculature of Brain Tumors and Preexistent Brain Capillaries

D. Ruiter, S. Duinen, G. Bots, 1988 .

Immunology of ocular tumours.

D. Ruiter, B. Ksander, M. Jager, 1999, Immunology today.

Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.

D. Ruiter, R. D. de Waal, R. Clarijs, 2002, Cancer research.

Immunohistochemistry in the evaluation of melanocytic tumors.

D. Ruiter, E. Bröcker, 1993, Seminars in diagnostic pathology.

Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome.

C. Figdor, C. Punt, D. Ruiter, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autosomal dominant epidermolysis bullosa dystrophics: are the Cockayne‐ Touraine, the Pasini and the Bart‐types different expressions of the same mutant gene?

D. Ruiter, A. Haeringen, J. Bavinck, 1987, Clinical genetics.

Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal mntibodies in cryostat sections of biopsies

D. Ruiter, E. Bröcker, C. Sorg, 2004, Cancer Immunology, Immunotherapy.

Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.

W. Oyen, T. Wobbes, T. Ruers, 2005, Surgery.

Immunopathology of Melanoma with Monoclonal Antibodies

D. Ruiter, S. Ferrone, G. Muijen, 1990 .

Complete response of melanoma-in-transit metastasis after isolated limb perfusion with tumor necrosis factor alpha and melphalan without massive tumor necrosis: a clinical and histopathological study of the delayed-type reaction pattern.

A. Eggermont, D. Ruiter, A. Eggermont, 1998, Cancer research.

In situ detection of supernumerary aberrations of chromosome-specific repetitive DNA targets in interphase nuclei in human melanoma cell lines and tissue sections.

D. Ruiter, D. Smeets, J. Beck, 1992, The Journal of investigative dermatology.

Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage

D. Ruiter, L. V. van Kempen, D. Roseeuw, 2006, The British journal of dermatology.

Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes

J. Lehmann, D. Ruiter, E. Bröcker, 1987, International journal of cancer.

Juxtacortical chondrosarcoma of the mandible: report of a unique case and review of the literature.

P. D. de Wilde, D. Ruiter, P. Slootweg, 2005, International journal of oral and maxillofacial surgery.

The role of amyloid in the pathogenesis of Alzheimer's disease.

M. Verbeek, D. Ruiter, R. D. de Waal, 1997, Biological chemistry.

Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.

P. Wesseling, M. Verbeek, D. Ruiter, 1994, The American journal of pathology.

Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.

P T de Jong, C M Mooy, P G Mulder, 1990, Ophthalmology.

Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.

D. Ruiter, E. van der Velde, S. Ferrone, 1988, Cancer research.

Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results.

D. Ruiter, M. Jager, J. Oosterhuis, 1990, The British journal of ophthalmology.

Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.

J. Becker, D. Ruiter, G. V. van Muijen, 2000, The Journal of investigative dermatology.

Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas

Ulrich Keilholz, D. Ruiter, A. Sutter, 1997 .

EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.

D. Ruiter, R. D. de Waal, R. Clarijs, 2003, Investigative ophthalmology & visual science.

Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer’s disease

M. Verbeek, R. Veerhuis, D. Ruiter, 1998, Acta Neuropathologica.

Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the A‚-containing lesions in brains of patients with dementia of the Alzheimer type

P. Wesseling, M. Verbeek, D. Ruiter, 1996, Acta Neuropathologica.

The efficacy of histopathological criteria required for diagnosing dysplastic naevi

D. Ruiter, W. Vloten, W. Bergman, 1988, Histopathology.

Suppression of class I human histocompatibility leukocyte antigen by c- myc is locus specific

H. Ploegh, R. Versteeg, D. Ruiter, 1989, The Journal of experimental medicine.

Soluble adhesion molecules in human cancers: sources and fates.

D. Ruiter, G. V. van Muijen, L. V. van Kempen, 2010, European journal of cell biology.

Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms

P. Wesseling, P. Burger, D. Ruiter, 1993, Acta Neuropathologica.

Advances in Brief Vascular Endothelial Growth Factor-A 165 Induces Progression of Melanoma Brain Metastases without Induction of Sprouting Angiogenesis 1

P. Wesseling, D. Ruiter, R. Waal, 2002 .

QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES DURING MALIGNANT PROGRESSION IN ASTROCYTIC NEOPLASMS

P. Wesseling, D. Ruiter, Jeroen A. W. M. van der Laak, 1996 .

Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation.

P T de Jong, M J Jager, D J Ruiter, 1988, American journal of ophthalmology.

Expression and activation of matrix metalloproteinase‐2 (MMP‐2) and its co‐localization with membrane‐type 1 matrix metalloproteinase (MT1‐MMP) correlate with melanoma progression

J. Becker, D. Ruiter, G. V. van Muijen, 2000 .

Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein.

D. Ruiter, A. Janssens, C. J. A. Van Den Hamer, 2008, Liver.

Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators

A. Eggermont, F. Sweep, D. Ruiter, 2000, International journal of cancer.

For personal use only. Reproduce with permission from The Lancet Publishing Group.

D. Ruiter, G. Muijen, J. Krieken, 2001 .

Expression of calcyclin in human melanocytic lesions.

D. Ruiter, G. V. van Muijen, H. Bloemers, 1993, Cancer research.

An altar in honor of the anatomical gift

J. Kooloos, D. Ruiter, J. van der Straaten, 2010, Anatomical sciences education.

Challenging students to formulate written questions: a randomized controlled trial to assess learning effects

J. Kooloos, D. Ruiter, R. D. de Waal, 2015, BMC medical education.

Consolidation Differentially Modulates Schema Effects on Memory for Items and Associations

Guillén Fernández, Mark Rijpkema, Dirk J. Ruiter, 2013, PloS one.

Marker in Human Cutaneous Melanoma Expression on Tumor Microvasculature as a New Progression Induction of Vascular Endothelial Growth Factor Receptor-3 Updated

D. Ruiter, R. Waal, R. Clarijs, 2002 .

No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited.

C. M. Mooy, M. J. Van der Helm, T. H. Van der Kwast, 1991, British Journal of Cancer.

Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy

N. de Leeuw, J. Galama, D. Ruiter, 2001, Transplant international : official journal of the European Society for Organ Transplantation.

Invasive cutaneous melanoma in The Netherlands, 1989-1990.

J. Coebergh, D. Ruiter, K. Welvaart, 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Integrin expression in uveal melanoma differs from cutaneous melanoma.

E. Danen, D. Ruiter, M. Jager, 1993, Investigative ophthalmology & visual science.

An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach.

A. Verbeek, D. Ruiter, P. Nelemans, 1995, Journal of clinical epidemiology.

Building on Prior Knowledge: Schema-dependent Encoding Processes Relate to Academic Performance

Guillén Fernández, Mark Rijpkema, Richard G. M. Morris, 2014, Journal of Cognitive Neuroscience.

NoN-rasmutations inhumanuveal melanoma: Therole ofultraviolet light revisited

E. Zwarthoff, P. deJong, D. Ruiter, 1991 .

Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group.

J. Schalken, F. Debruyne, D. Ruiter, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Angiogenesis in wound healing and tumor metastasis.

D. Ruiter, R. D. de Waal, R. Schlingemann, 1993, Behring Institute Mitteilungen.

Uncovering students’ misconceptions by assessment of their written questions

J. Kooloos, D. Ruiter, R. D. de Waal, 2016, BMC medical education.

A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques

P. Wesseling, M. Verbeek, D. Ruiter, 2004, Acta Neuropathologica.

Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma.

P. van den Broek, J. Verweij, J. Schornagel, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Functional and morphologic analysis of the fluid-conducting meshwork in xenografted cutaneous and primary uveal melanoma.

D. Ruiter, R. D. de Waal, R. Clarijs, 2005, Investigative ophthalmology & visual science.

Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions.

J. Johnson, D. Ruiter, G. V. van Muijen, 1990, The Journal of investigative dermatology.

Computer-assisted analysis of the microvasculature in untreated glioblastomas

P. Wesseling, P. Burger, D. Ruiter, 2005, Journal of Neuro-Oncology.

Monoclonal antibody MS-44B reacts with human dendritic, glial and endothelial cells: differential expression of MS-44B antigen by epidermal dendritic cells and by MS-1+ splenic sinusoidal endothelial cells. An immunohistological study.

S. Goerdt, D. Ruiter, E. Bröcker, 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.

Regulation of integrin‐mediated adhesion to laminin and collagen in human melanocytes and in non‐metastatic and highly metastatic human melanoma cells

C. Figdor, E. Danen, D. Ruiter, 1993, International journal of cancer.

Erratum: Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas. Int. J. Cancer, 71, 320–324 (1997)

D. Ruiter, A. Sutter, S. Goodman, 1997 .

Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics.

D. Ruiter, E. Bröcker, R. D. de Waal, 1996, Journal of Investigative Dermatology.

Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.

D. Ruiter, R. D. de Waal, R. Clarijs, 2002, Investigative ophthalmology & visual science.

Explicit feedback to enhance the effect of an interim assessment: a cross-over study on learning effect and gender difference

R. Donders, D. Ruiter, R. D. de Waal, 2012, Perspectives on medical education.

Clinical and pathologic diagnosis, staging and prognostic factors of melanoma, and management of primary disease

D. Ruiter, 1992, Current opinion in oncology.

Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma.

A. Heerschap, P. Wesseling, J. Barentsz, 2003, Cancer research.

Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.

E. Danen, D. Ruiter, G. V. van Muijen, 1995, International journal of cancer.

Report on consensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Results of a workshop held under the auspices of the EEC Europe against cancer programme in Innsbruck, April 1991.

M. Aapro, D. Ruiter, R. MacKie, 1991, European journal of cancer.

CORRESPONDENCE

D. Ruiter, W. Mooi, W. Bergman, 1989 .

HISTOPATHOLOGICAL AsPECTS OF DYSPLASTIC NEVI

D. Ruiter, W. Bergman, E. Scheffer, 1984 .

Histopathological and Cytopathological Aspects of Focal Liver Lesions

D. Ruiter, G. Steenis, 1984 .

Diffusion tensor characteristics of gyrencephaly using high resolution diffusion MRI in vivo at 7T

David G. Norris, Michiel Kleinnijenhuis, Anne-Marie van Cappellen van Walsum, 2015, NeuroImage.

Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals.

A. Verbeek, D. Ruiter, P. Nelemans, 1993, Environmental health perspectives.

Immunodiagnostic and immunotherapeutic applications of anti human melanoma associated antigen monoclonal antibodies.

D. Ruiter, S. Ferrone, P. Natali, 1989, Carcinogenesis; a comprehensive survey.

[Guideline 'Melanoma' (3rd revision)].

J. Coebergh, C. Koning, D. Ruiter, 2005, Nederlands tijdschrift voor geneeskunde.

Challenging medical students with an interim assessment: a positive effect on formal examination score in a randomized controlled study

Dirk J. Ruiter, R. Donders, D. Ruiter, 2011, Advances in Health Sciences Education.

Histopathologic findings in explanted heart tissue from patients with end‐stage idiopathic dilated cardiomyopathy

J. Galama, D. Ruiter, W. Melchers, 2001 .

Design of a Variant of Vascular Endothelial Growth Factor-A (VEGF-A) Antagonizing KDR/Flk-1 and Flt-1

D. Ruiter, R. Waal, G. Breier, 2002, Laboratory Investigation.

An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1.

E. Lane, H. Kremer, D. Ruiter, 1998, The Journal of investigative dermatology.

Progression markers in metastasizing human melanoma cells xenografted to nude mice (review).

D. Ruiter, G. V. van Muijen, I. Cornelissen, 1989, Anticancer research.

Legionnaires' disease: case report with special emphasis on electron microscopy and potential risk of infection at autopsy

D. Ruiter, C. Meijer, P. Meenhorst, 1979, Histopathology.

Atypical indifferent (reserve) cells in the cervical epithelium and their exfoliative pattern.

D. Ruiter, M. Boon, 1982, Acta cytologica.

Distribution of major histocompatibility antigens in normal skin.

M. Mihm, D. Ruiter, A. Bhan, 1986, The British journal of dermatology.

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis.

D. Schadendorf, A. Eggermont, D. Ruiter, 2004, European journal of cancer.

Self-Reflecting Methods of Learning Research

Chris L. S. Coryn, Daniel A. Braun, Michael E. Lusignan, 2012 .

Prognostic significance of melanoma-associated antigens in primary and metastatic melanomas

D. Ruiter, E. Bröcker, E. Macher, 1984 .

Melanoma progression in a changing environment.

D. Ruiter, G. V. van Muijen, L. V. van Kempen, 2007, European journal of cell biology.

Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease.

M. Verbeek, D. Ruiter, R. D. de Waal, 1999, Cellular and molecular biology.

Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

M. Verbeek, R. Veerhuis, D. Ruiter, 1998, Acta Neuropathologica.

How schema and novelty augment memory formation

R. Henson, G. Fernández, M. V. Kesteren, 2012, Trends in Neurosciences.

Epidemiology, Precursors, and Markers of Malignant Melanoma

M. Mihm, A. Kopf, R. Friedman, 1988 .

Dendritic reticulum cell sarcoma: a rare tumor of the follicular compartment.

D. Ruiter, C. Meijer, G. Den Ottolander, 1982, Advances in experimental medicine and biology.

Immunohistopathological Aspects of Cutaneous Melanoma and Precursor Lesions

D. Ruiter, S. Duinen, S. Warnaar, 1984 .

Melanocytic Tumor Progression Receptor-associated Protein in Late Stages of Cutaneous-Macroglobulin Receptor and Its 2 α Receptor-related Protein / Decreased Expression of Both the Low-Density Lipoprotein Updated

U. Weidle, D. Ruiter, J. Verheijen, 2006 .

Case 5: Type of Epitheloid and Clear Cell Cancer?

D. Ruiter, A. Taminiau, 1987 .